We also found that GBM-N019 halted the exosomal cargo delivery of Akt, mTOR, p-mTOR, and RAB27A, and attenuated the tumorsphere-derived exosomes (exosphere; Exosp) mediated drug resistance and aggressive phenotypes of GBM. The gene discussed is AKT1; the disease is glioblastoma.